NR4A1 and breast cancer: From an immunohistochemical point of view, BC is further classified based on the protein expression of hormone receptors (HR), such as estrogen receptor (ER) and progesterone receptor (PR), as well as of epidermal growth factor receptor 2 (HER2, encoded by the ERBB2 gene), along with the expression of the proliferation marker Ki67.